Beigene, Ltd. (NASDAQ:ONC – Get Free Report) Director Bros. Advisors Lp Baker sold 732,827 shares of Beigene stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $260.00, for a total transaction of $190,535,020.00. Following the completion of the transaction, the director now directly owns 730,642 shares in the company, valued at approximately $189,966,920. This trade represents a 50.07 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Beigene Price Performance
Beigene stock opened at $271.80 on Friday. Beigene, Ltd. has a fifty-two week low of $126.97 and a fifty-two week high of $287.88. The company has a market capitalization of $26.60 billion, a PE ratio of -32.99, a PEG ratio of 7.73 and a beta of 0.63. The company has a current ratio of 1.93, a quick ratio of 1.72 and a debt-to-equity ratio of 0.05.
Beigene (NASDAQ:ONC – Get Free Report) last announced its quarterly earnings data on Thursday, February 27th. The company reported ($1.43) EPS for the quarter, missing analysts’ consensus estimates of ($0.88) by ($0.55). Beigene had a negative net margin of 25.94% and a negative return on equity of 25.12%. The company had revenue of $1.13 billion for the quarter, compared to analysts’ expectations of $1.09 billion. On average, analysts forecast that Beigene, Ltd. will post -5.82 EPS for the current year.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Report on ONC
Beigene Company Profile
BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.
Featured Articles
- Five stocks we like better than Beigene
- How to Evaluate a Stock Before Buying
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- How to Invest in Blue Chip Stocks
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- Manufacturing Stocks Investing
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for Beigene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beigene and related companies with MarketBeat.com's FREE daily email newsletter.